Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R. Mehra, Frank Ruschitzka, Amit Patel
The Lancet (2020) Vol. 395, Iss. 10240, pp. 1820-1820
Open Access | Times Cited: 558

Showing 1-25 of 558 citing articles:

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Qianqian Zhang, Rong Xiang, Shanshan Huo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 300
Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science
Jon Agley, Yunyu Xiao
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 235
COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)
Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240011-e0240011
Open Access | Times Cited: 210
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, et al.
JAMA Network Open (2021) Vol. 4, Iss. 7, pp. e2116901-e2116901
Open Access | Times Cited: 208
Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework
Quan‐Hoang Vuong, Tam-Tri Le, Viet‐Phuong La, et al.
Humanities and Social Sciences Communications (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 202
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses
Shirley Wang, Sebastian Schneeweiß, Jessica M. Franklin, et al.
JAMA (2023) Vol. 329, Iss. 16, pp. 1376-1376
Open Access | Times Cited: 192
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients
Xiaoli Wang, Xianghua Guo, Qianqian Xin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 166
COVID-19: a review
Constantinos Papadopoulos, Sebastian Chong, Shameen Jaunoo
IJS Short Reports (2020) Vol. 5, Iss. 1, pp. e07-e07
Open Access | Times Cited: 166
SARS-CoV-2: characteristics and current advances in research
Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 151
The carnage of substandard research during the COVID-19 pandemic: a call for quality
Katrina A. Bramstedt
Journal of Medical Ethics (2020) Vol. 46, Iss. 12, pp. 803-807
Closed Access | Times Cited: 146
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic
Richard A. Neher, Robert Dyrdak, Valentin Druelle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 144
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
Malaria and COVID-19: unmasking their ties
Mogahed Ismail Hassan Hussein, Ahmed Abdalazim Dafallah Albashir, Omer Ali Mohamed Ahmed Elawad, et al.
Malaria Journal (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 141
COVID-19 and the Kidneys: An Update
Claudia Benedetti, Meryl Waldman, Gianluigi Zaza, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 140
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Yao Zhao, Xiaoyu Du, Yinkai Duan, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 877-888
Open Access | Times Cited: 134
Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview
Arianna Dagliati, Alberto Malovini, Valentina Tibollo, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 812-822
Open Access | Times Cited: 107
COVID-19 drug discovery and treatment options
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 17
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R. Rivera, Solange Peters, Orestis A. Panagiotou, et al.
Cancer Discovery (2020) Vol. 10, Iss. 10, pp. 1514-1527
Open Access | Times Cited: 131
False individual patient data and zombie randomised controlled trials submitted to Anaesthesia
J. B. Carlisle
Anaesthesia (2020) Vol. 76, Iss. 4, pp. 472-479
Closed Access | Times Cited: 114
Is hydroxychloroquine beneficial for COVID-19 patients?
Xing Li, Ying Wang, Patrizia Agostinis, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 7
Open Access | Times Cited: 111
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
European Journal of Internal Medicine (2020) Vol. 82, pp. 38-47
Open Access | Times Cited: 110
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
Arunmozhimaran Elavarasi, Manya Prasad, Tulika Seth, et al.
Journal of General Internal Medicine (2020) Vol. 35, Iss. 11, pp. 3308-3314
Open Access | Times Cited: 108
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
Roland Derwand, Martin Scholz, Vladimir Zelenko
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106214-106214
Open Access | Times Cited: 102
Page 1 - Next Page

Scroll to top